Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating Aldesleukin with or without vaccine therapy in Stage IV melanoma has completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Melanoma Biomarker Study
The clinical trial update notes the biomarker study in metastatic melanoma reaching completion.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer [Phase 2]
Phase II study evaluating Aldesleukin (IL-2) after Zanolimumab in metastatic melanoma and metastatic renal cell carcinoma was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2012-12-10Clinical Trial Update: A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating the safety and antitumor activity of IPI-504 in patients with metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients [Phase 1]
A Phase 1 trial assessing the safety and tolerability of intradermal IMM-101 in adults with melanoma; the study was completed and results we…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes [Phase 2]
Phase II trial evaluating lymphodepleting conditioning plus anti-gp100:154-162 TCR-engineered lymphocytes in metastatic melanoma. The study …
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating cyclophosphamide and fludarabine followed by cellular adoptive immunotherapy and vaccine therapy in metastatic mela…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma [Phase 2]
Phase 2 clinical trial evaluating a universal GM-CSF-producing and CD40L-expressing bystander cell line as a tumor vaccine for melanoma; the…
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer [Phase 2]
Phase 2 trial evaluating natural killer cell therapy plus interleukin-2 after chemotherapy in advanced melanoma and metastatic kidney cancer…
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma [Phase 2]
Phase 2 clinical trial in metastatic melanoma evaluating radiation, chemotherapy, a melanoma vaccine, and anti-MART-1 and anti-GP100 cell th…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma [Phase 2]
A Phase 2 trial evaluated lenalidomide (Revlimid) for advanced ocular (uveal) melanoma; the study completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial update evaluating chemotherapy, irradiation, cell infusions, and interleukin-2 for metastatic melanoma. Results wer…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial of Interleukin-7 in patients with metastatic melanoma or renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
A completed clinical trial examining the role of miRNA machinery in cutaneous melanoma, metastatic melanoma, and benign melanocytic nevi.
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis [NA]
Clinical trial update noting completion of a study evaluating in vivo confocal microscopy for diagnosing pigmented skin lesions, including m…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with or without sorafenib tosylate in patients with unresectable stage III or stage IV m…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Stage IV Surgery Versus Best Medical Therapy [Phase 3]
A Phase 3 trial comparing surgery versus best medical therapy for stage IV resectable melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa [Phase 1, Phase 2]
Update on a completed Phase 1/Phase 2 clinical trial evaluating post-operative adjuvant radiotherapy with concurrent Interferon-Alpha in mel…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured [Phase 1]
Phase 1 trial of an Ad-CCL-21–transduced, peptide-pulsed dendritic cell vaccine targeting MART-1, gp100, tyrosinase, and NY-ESO-1 in melanom…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain [Phase 3]
A Phase 3 trial evaluating temozolomide with or without brain radiation therapy in patients with stage IV melanoma that has metastasized to …
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma [Phase 3]
Phase 3 trial (S0008) comparing chemotherapy plus biological therapy for melanoma has completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain [Phase 2]
A Phase 2 clinical trial evaluating conformal radiation therapy for metastatic cancers outside the brain was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 trial evaluating thalidomide plus temozolomide for patients with stage IV melanoma that cannot be surgically removed has completed…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: S9804: Vinorelbine in Treating Patients With Stage IV Melanoma [Phase 2]
SWOG's Phase 2 trial S9804 evaluated vinorelbine in patients with stage IV melanoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Can We Miss Pigmented Lesions in Psoriasis Patients? [Phase 4]
Phase 4 clinical trial assessing detection of pigmented lesions in psoriasis patients; completed with results posted in 2012.